{"id":15207,"date":"2026-06-03T12:07:00","date_gmt":"2026-06-03T10:07:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=34873bf78601a4713f1cd06abc2abbd6"},"modified":"2026-06-03T12:07:00","modified_gmt":"2026-06-03T10:07:00","slug":"av-laboratories-defines-a-new-skincare-standard-for-the-glp-1-era-molecular-nourishment-designed-to-support-skin-through-weight-loss-and-beyond","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=15207","title":{"rendered":"AV Laboratories Defines a New Skincare Standard for the GLP-1 Era: Molecular Nourishment Designed to Support Skin Through Weight Loss and Beyond"},"content":{"rendered":"<p>\n<b>Following the Aesthetic &amp; Anti-Aging Medicine World Congress (AMWC) in Monaco, AV Laboratories establishes 360\u00b0 molecular nourishment as an essential skincare partner to GLP-1-driven transformation. Powered by patented AVL SOM3\u00ae technology, the brand\u2019s approach supports the appearance of hydrated, resilient, younger-looking skin as the body moves through weight loss.<\/b><\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260602498086\/en\/2822641\/5\/AVL_GLP1_Monoco.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260602498086\/en\/2822641\/22\/AVL_GLP1_Monoco.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260602498086\/en\/2822641\/5\/AVL_GLP1_Monoco.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260602498086\/en\/2822641\/21\/AVL_GLP1_Monoco.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260602498086\/en\/2822640\/5\/AVL_LogoGRN_%284%29.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260602498086\/en\/2822640\/22\/AVL_LogoGRN_%284%29.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260602498086\/en\/2822640\/5\/AVL_LogoGRN_%284%29.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260602498086\/en\/2822640\/21\/AVL_LogoGRN_%284%29.jpg\" \/><\/a><p>MONACO--(BUSINESS WIRE)--<a href=\"https:\/\/twitter.com\/hashtag\/AMWC?src=hash\" >#AMWC<\/a>--As GLP-1 medications continue to reshape the global conversation around weight loss, metabolic health, and long-term wellness, AV Laboratories brought a new skincare standard to the Aesthetic &amp; Anti-Aging Medicine World Congress in Monaco: topical molecular nourishment designed to support the appearance of healthy, resilient, younger-looking skin throughout the weight loss journey.<\/p><p>\nAt the conference, AV Laboratories joined the global aesthetic medicine conversation with a clear message: as GLP-1s transform the way patients approach weight loss and metabolic health, skincare must evolve to support the visible quality of the skin through that transformation. The brand shared its 360\u00b0 molecular nourishment approach with physicians, aesthetic professionals, and clinic leaders, highlighting the role patented AVL SOM3\u00ae technology can play in supporting hydrated, resilient, younger-looking skin.<\/p><p>\nAt AMWC, AV Laboratories also continued to expand its international scientific perspective by exchanging knowledge with physicians and aesthetic experts from around the world. The brand is closely following the emerging discussion on how rapid metabolic change may affect skin quality \u2014 not only through facial fat loss, but also through broader biological factors such as adipose tissue dynamics, dermal white adipose tissue, fibroblast signalling, collagen metabolism, hormonal balance, cellular energy and nutrient availability.<\/p><p>\n\u201cRapid physical change can place new demands on the skin\u2019s appearance, and new demands require a more intelligent skincare approach,\u201d said <b>Sylwia Pawlaczyk, COO and Master Formulator at AV Laboratories<\/b>. \u201cAVL SOM3\u00ae was developed to help support the skin\u2019s natural renewal environment with molecular building blocks associated with healthier-looking skin over time.\u201d<\/p><p>\nDuring rapid weight loss, especially when appetite is reduced, nutritional intake may become insufficient. Protein intake is particularly important because amino acids are essential building blocks for collagen, elastin, and structural proteins associated with healthy-looking, resilient skin. Because the skin is not a survival-priority organ, reduced nutrient availability may become visible through changes in glow, comfort, hydration, texture, and the appearance of firmness.<\/p><p>\n<b>AVL SOM3\u00ae: 360\u00b0 Molecular Nourishment for the GLP-1 Era<\/b><\/p><p>\nAt the center of AV Laboratories\u2019 approach is AVL SOM3\u00ae, the brand\u2019s patented longevity skincare technology. Founded by Ami and Monica Mezezi, pioneers in IVF solutions, regenerative medicine, and cellular science, AVL SOM3\u00ae was designed to support skin with a precise matrix of molecular nourishment, including all 20 amino acids, empowering the skin to support collagen, elastin and NAD+ naturally.<\/p><p>\n\u201cOur work in IVF taught us how profoundly cellular health, precision, and care matter,\u201d said Ami Mezezi, CEO and Co-Founder of AV Laboratories. \u201cWith AV Laboratories, we are bringing that same philosophy into skincare. As GLP-1s reshape how people think about metabolic health and longevity, skin deserves the same level of intelligent support, precision, and nourishment.\u201d<\/p><p>\nEach AV Laboratories formula pairs AVL SOM3\u00ae with clinical-grade actives selected to support the appearance of hydrated, smoother, firmer-looking skin. Rather than focusing on a single visible concern, AVL SOM3\u00ae reflects a 360\u00b0 nourishment platform designed to support the key visible pillars associated with younger-looking skin: structure, elasticity, hydration, barrier resilience, and the appearance of cellular energy.<\/p><p>\nFor Dr. Olena Ivchenko, Scientific Advisory Board Member at AV Laboratories, the GLP-1 era reinforces the need for integrated care across health, aesthetics, and skin quality.<\/p><p>\n\u201cAs more patients experience meaningful weight loss and metabolic change, the conversation naturally expands to how they feel in their skin,\u201d said Dr. Ivchenko. \u201cIn aesthetic and longevity medicine, we look at the full picture: nutrition, hormones, lifestyle, medical care, and skin quality. Topical skin nourishment can be an important part of helping patients maintain a healthy-looking, resilient, radiant appearance throughout their transformation.\u201d<\/p><p>\nAs GLP-1s continue to influence medicine, aesthetics, and consumer behavior, AV Laboratories is defining 360\u00b0 molecular nourishment as the essential topical skincare standard for this new era. Powered by patented AVL SOM3\u00ae technology, the brand\u2019s approach supports the appearance of hydrated, resilient, younger-looking skin as the body moves through weight loss.<\/p><p>\n<b>About AV Laboratories<\/b><\/p><p>\nAV Laboratories is a science-led skincare company founded by pioneers in IVF solutions, regenerative medicine, and cellular science. The company develops advanced skincare solutions rooted in its patented AVL SOM3\u00ae technology, empowering skin to renew, restore and rejuvenate for younger looking skin for longer.<\/p><br\/> <b>Contacts<\/b> <br\/><p>\nMedia Contact\n<br\/>Marlee Martinez\n<br\/>PR Contact\n<br\/><a  href=\"mailto:marlee@valleymade.co\" rel=\"nofollow\" shape=\"rect\">marlee@valleymade.co<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Following the Aesthetic &amp; Anti-Aging Medicine World Congress (AMWC) in Monaco, AV Laboratories establishes 360\u00b0 molecular nourishment as an essential skincare partner to GLP-1-driven transformation. Powered by patented AVL SOM3\u00ae technology, the br&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-15207","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/15207","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15207"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/15207\/revisions"}],"predecessor-version":[{"id":15208,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/15207\/revisions\/15208"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15207"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15207"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15207"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}